Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 132 articles:
HTML format

Single Articles

    January 2022
  1. ZHU C, Zhong L, Lin M, Tian C, et al
    The value of TI-RADS combined with superb micro-vascular imagine in distinguishing benign and malignant thyroid nodules: A meta-analysis.
    PLoS One. 2022;17:e0261521.
    PubMed     Abstract available

  2. WANG SW, Chan LP, Wang LF, Wu CW, et al
    Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.
    PLoS One. 2022;17:e0263773.
    PubMed     Abstract available

  3. KANAMARLAPUDI V, Tamaddon-Jahromi S, Murphy K
    ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.
    PLoS One. 2022;17:e0263845.
    PubMed     Abstract available

  4. MORNA MT, Tuoyire DA, Jimah BB, Eliason S, et al
    Prevalence and characterization of asymptomatic thyroid nodules in Assin North District, Ghana.
    PLoS One. 2022;17:e0263365.
    PubMed     Abstract available

  5. SUZUKI S, Toyoma S, Kawasaki Y, Yamada T, et al
    Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0262549.
    PubMed     Abstract available

  6. ZHANG X, Lee VCS, Rong J, Liu F, et al
    Multi-channel convolutional neural network architectures for thyroid cancer detection.
    PLoS One. 2022;17:e0262128.
    PubMed     Abstract available

  7. VERYASKINA YA, Titov SE, Ivanov MK, Ruzankin PS, et al
    Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer.
    PLoS One. 2022;17:e0254304.
    PubMed     Abstract available

  8. HO SY, Kao WC, Hsiao SY, Chiu SF, et al
    Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.
    PLoS One. 2022;17:e0266678.
    PubMed     Abstract available

  9. ABUSALAH MAH, Irekeola AA, Hanim Shueb R, Jarrar M, et al
    Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0266893.
    PubMed     Abstract available

  10. SHENG S, Su W, Mao D, Li C, et al
    MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0267017.
    PubMed     Abstract available

  11. ROUMANS CAM, Spaander MCW, Lansdorp-Vogelaar I, Biermann K, et al
    A personalized and dynamic risk estimation model: The new paradigm in Barrett's esophagus surveillance.
    PLoS One. 2022;17:e0267503.
    PubMed     Abstract available

  12. BADRI P, Baracos V, Ganatra S, Lai H, et al
    Retrospective study of factors associated with late detection of oral cancer in alberta: A qualitative study.
    PLoS One. 2022;17:e0266558.
    PubMed     Abstract available

  13. RIBEIRO-ROTTA RF, Rosa EA, Milani V, Dias NR, et al
    The cost of oral cancer: A systematic review.
    PLoS One. 2022;17:e0266346.
    PubMed     Abstract available

  14. ELLIS BG, Whitley CA, Triantafyllou A, Gunning PJ, et al
    Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    PLoS One. 2022;17:e0266043.
    PubMed     Abstract available

  15. XIE L, Shang Z
    Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.
    PLoS One. 2022;17:e0265950.
    PubMed     Abstract available

  16. ALI A, Rumbold AR, Kapellas K, Lassi ZS, et al
    Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
    PLoS One. 2022;17:e0265840.
    PubMed     Abstract available

  17. ZHANG ZJ, Shi LL, Hong XH, Xiao BY, et al
    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
    PLoS One. 2022;17:e0265551.
    PubMed     Abstract available

  18. NIK JAAFAR NR, Hamdan NA, Abd Hamid N, Rajandram RK, et al
    Posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients.
    PLoS One. 2022;17:e0265502.
    PubMed     Abstract available

  19. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed     Abstract available

  20. GRASS JK, Kusters N, Kemper M, Tintrup J, et al
    Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
    PLoS One. 2022;17:e0265093.
    PubMed     Abstract available

  21. BROUWER AF, Campredon LP, Walline HM, Marinelli BM, et al
    Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.
    PLoS One. 2022;17:e0268104.
    PubMed     Abstract available

  22. MIAO L, Lv X, Huang C, Li P, et al
    Long-term oncological outcomes after oral cancer surgery using propofol-based total intravenous anesthesia versus sevoflurane-based inhalation anesthesia: A retrospective cohort study.
    PLoS One. 2022;17:e0268473.
    PubMed     Abstract available

  23. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    PubMed     Abstract available

  24. ADNAN Y, Ali SMA, Awan MS, Idress R, et al
    Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
    PLoS One. 2022;17:e0267300.
    PubMed     Abstract available

  25. ZHANG Z, Leong Bin Abdullah MFI, Shari NI, Lu P, et al
    Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life.
    PLoS One. 2022;17:e0267887.
    PubMed     Abstract available

  26. BLATT S, Kruger M, Rump C, Zimmer S, et al
    Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0269136.
    PubMed     Abstract available

  27. KOSKINEN A, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
    PLoS One. 2022;17:e0268922.
    PubMed     Abstract available

  28. HU C, Fan J, He G, Dong C, et al
    Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0269166.
    PubMed     Abstract available

  29. TANG Q, Pan W, Peng L
    Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
    PLoS One. 2022;17:e0269995.
    PubMed     Abstract available

  30. LIANG Y, Huang X, Song Z, Yang Y, et al
    Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8th staging criteria.
    PLoS One. 2022;17:e0269994.
    PubMed     Abstract available

  31. DU Q, Xiao RD, Luo RG, Xie JB, et al
    Construction of long non-coding RNA- and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer.
    PLoS One. 2022;17:e0269742.
    PubMed     Abstract available

  32. UEDA T, Yumii K, Urabe Y, Chikuie N, et al
    Swallowing function after transoral surgery for laryngopharyngeal cancer.
    PLoS One. 2022;17:e0270509.
    PubMed     Abstract available

  33. MARBANIANG I, Joshi S, Sangle S, Khaire S, et al
    Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV.
    PLoS One. 2022;17:e0270876.
    PubMed     Abstract available

  34. WU L, Jiang C, Zhu Z, Sun Y, et al
    Prognostic role of PD-L1 expression in patients with salivary gland carcinoma: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272080.
    PubMed     Abstract available

  35. AHN HS, Kim HS, Hong MJ
    Ultrasonographic and cytologic assessments of follicular neoplasms of the thyroid: Predictive features differentiating follicular carcinoma from follicular adenoma.
    PLoS One. 2022;17:e0271437.
    PubMed     Abstract available

  36. WANG B, Jiang W, Zheng X, Han Y, et al
    Research on a Weighted Gene Co-expression Network Analysis method for mining pathogenic genes in thyroid cancer.
    PLoS One. 2022;17:e0272403.
    PubMed     Abstract available

  37. WAKASAKI T, Manako T, Yasumatsu R, Hara H, et al
    Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
    PLoS One. 2022;17:e0271907.
    PubMed     Abstract available

  38. WANG Z, Luo J, Zhang Y, Xun P, et al
    Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0271038.
    PubMed     Abstract available

  39. STENMAN S, Linder N, Lundin M, Haglund C, et al
    A deep learning-based algorithm for tall cell detection in papillary thyroid carcinoma.
    PLoS One. 2022;17:e0272696.
    PubMed     Abstract available

  40. GUO Y, Xu M, Lou Y, Yuan Y, et al
    Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis.
    PLoS One. 2022;17:e0271242.
    PubMed     Abstract available

  41. ZHONG L, Wang C
    Diagnostic accuracy of S-Detect in distinguishing benign and malignant thyroid nodules: A meta-analysis.
    PLoS One. 2022;17:e0272149.
    PubMed     Abstract available

  42. CHOI KH, Song JH, Hong JH, Lee YS, et al
    Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment.
    PLoS One. 2022;17:e0273059.
    PubMed     Abstract available

  43. WARIN K, Limprasert W, Suebnukarn S, Jinaporntham S, et al
    AI-based analysis of oral lesions using novel deep convolutional neural networks for early detection of oral cancer.
    PLoS One. 2022;17:e0273508.
    PubMed     Abstract available

  44. LIU Q, Du J, Li Y, Peng G, et al
    Uncovering nasopharyngeal carcinoma from chronic rhinosinusitis and healthy subjects using routine medical tests via machine learning.
    PLoS One. 2022;17:e0274263.
    PubMed     Abstract available

  45. JOUHI L, Sikio J, Suomalainen A, Mroueh R, et al
    Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer.
    PLoS One. 2022;17:e0274813.
    PubMed     Abstract available

  46. HUR JY, Ku BM, Park S, Jung HA, et al
    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0274830.
    PubMed     Abstract available

  47. CHANG YL, Cheng YF, Chen HS, Wu SC, et al
    Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0271338.
    PubMed     Abstract available

  48. CABUZU D, Ramakrishnan SK, Moor MB, Harmacek D, et al
    Loss of Ecrg4 improves calcium oxalate nephropathy.
    PLoS One. 2022;17:e0275972.
    PubMed     Abstract available

  49. ZHU Z, Yu S, Niu K, Wang P, et al
    LGR5 promotes invasion and migration by regulating YAP activity in hypopharyngeal squamous cell carcinoma cells under inflammatory condition.
    PLoS One. 2022;17:e0275679.
    PubMed     Abstract available

  50. TAKENAKA Y, Uno A, Tanaka H, Takemoto N, et al
    Radiation vs surgery for early-stage laryngeal verrucous carcinoma: A population-based propensity score matched-study.
    PLoS One. 2022;17:e0275271.
    PubMed     Abstract available

  51. LIN CH, Chuang HN, Hsiao TH, Kumar VB, et al
    AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0276990.
    PubMed     Abstract available

  52. PANDA S, Sakthivel P, Gurusamy KS, Sharma A, et al
    Treatment options for resectable hypopharyngeal squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0277460.
    PubMed     Abstract available

  53. JOVANOVIC N, Chinnery T, Mattonen SA, Palma DA, et al
    Sarcopenia in head and neck cancer: A scoping review.
    PLoS One. 2022;17:e0278135.
    PubMed     Abstract available

    January 2021
  54. MATSUOKA Y, Al-Shareef H, Kogo M, Nakahara H, et al
    Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro.
    PLoS One. 2021;16:e0212323.
    PubMed     Abstract available

  55. HE L, Zhao W, Xia Z, Su A, et al
    Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: Systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0243864.
    PubMed     Abstract available

  56. CHIANG TE, Lin YC, Wu CT, Yang CY, et al
    Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.
    PLoS One. 2021;16:e0244740.
    PubMed     Abstract available

  57. VERZA FA, Valente VB, Oliveira LK, Kayahara GM, et al
    Social isolation stress facilitates chemically induced oral carcinogenesis.
    PLoS One. 2021;16:e0245190.
    PubMed     Abstract available

  58. WANG C, Lin M, Zhong L, Tian C, et al
    The value of TI-RADS combined with superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis.
    PLoS One. 2021;16:e0245035.
    PubMed     Abstract available

  59. CHUANG FC, Wang CC, Chen JH, Hwang TZ, et al
    PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
    PLoS One. 2021;16:e0245715.
    PubMed     Abstract available

  60. CHAMBARA N, Liu SYW, Lo X, Ying M, et al
    Diagnostic performance evaluation of different TI-RADS using ultrasound computer-aided diagnosis of thyroid nodules: An experience with adjusted settings.
    PLoS One. 2021;16:e0245617.
    PubMed     Abstract available

  61. MOHAMMADI N, Alimohammadian M, Feizesani A, Poustchi H, et al
    The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: An analysis of 49,946 cases in the Golestan Cohort Study, Iran.
    PLoS One. 2021;16:e0246004.
    PubMed     Abstract available

  62. MILANI V, Zara ALSA, da Silva EN, Cardoso LB, et al
    Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
    PLoS One. 2021;16:e0246475.
    PubMed     Abstract available

  63. CHENG PC, Chang CM, Liao LJ, Cheng PW, et al
    The outcomes and decision-making process for neck lymph nodes with indeterminate fine-needle aspiration cytology.
    PLoS One. 2021;16:e0246437.
    PubMed     Abstract available

  64. WALLANDER K, Eisfeldt J, Lindblad M, Nilsson D, et al
    Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    PLoS One. 2021;16:e0245488.
    PubMed     Abstract available

  65. EVEN C, Sagaon Teyssier L, Pointreau Y, Temam S, et al
    Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
    PLoS One. 2021;16:e0246252.
    PubMed     Abstract available

  66. LIU CH, Chang JT, Lee TH, Chang PY, et al
    Total plaque score helps to determine follow-up strategy for carotid artery stenosis progression in head and neck cancer patients after radiation therapy.
    PLoS One. 2021;16:e0246684.
    PubMed     Abstract available

  67. HUTAJULU SH, Howdon D, Taroeno-Hariadi KW, Hardianti MS, et al
    Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.
    PLoS One. 2021;16:e0246638.
    PubMed     Abstract available

  68. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed     Abstract available

  69. NANNAPANENI S, Griffith CC, Magliocca KR, Chen W, et al
    Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0247498.
    PubMed     Abstract available

  70. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    PubMed     Abstract available

  71. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available

  72. AL-SALAM S, Sharma C, Abu Sa'a MT, Afandi B, et al
    Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
    PLoS One. 2021;16:e0247807.
    PubMed     Abstract available

  73. AMRENOVA A, Suzuki K, Saenko V, Yamashita S, et al
    Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.
    PLoS One. 2021;16:e0249059.
    PubMed     Abstract available

  74. SHRIDHAR K, Aggarwal A, Rawal I, Gupta R, et al
    Feasibility of investigating the association between bacterial pathogens and oral leukoplakia in low and middle income countries: A population-based pilot study in India.
    PLoS One. 2021;16:e0251017.
    PubMed     Abstract available

  75. LORENZATTI HILES G, Chang KP, Bellile EL, Wang CI, et al
    Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    PLoS One. 2021;16:e0250530.
    PubMed     Abstract available

  76. YAGYUU T, Funayama N, Imada M, Kirita T, et al
    Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
    PLoS One. 2021;16:e0250359.
    PubMed     Abstract available

  77. LEE PY, Lai JN, Chiu LT, Wei YT, et al
    Incidence and time trends of herpes zoster among patients with head and neck cancer who did and did not undergo radiotherapy: A population-based cohort study.
    PLoS One. 2021;16:e0250724.
    PubMed     Abstract available

  78. BAE YJ, Kim TE, Choi BS, Jeong WJ, et al
    Comprehensive assessments of the open mouth dynamic maneuver and metal artifact reduction algorithm on computed tomography images of the oral cavity and oropharynx.
    PLoS One. 2021;16:e0248696.
    PubMed     Abstract available

  79. SHIN YJ, Vu H, Lee JH, Kim HD, et al
    Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
    PLoS One. 2021;16:e0248167.
    PubMed     Abstract available

  80. CAMPOS-DELGADO DU, Gutierrez-Navarro O, Salinas-Martinez R, Duran E, et al
    Blind deconvolution estimation by multi-exponential models and alternated least squares approximations: Free-form and sparse approach.
    PLoS One. 2021;16:e0248301.
    PubMed     Abstract available

  81. ZHEN J, Song Z, Su W, Zeng QC, et al
    Integrated analysis of RNA-binding proteins in thyroid cancer.
    PLoS One. 2021;16:e0247836.
    PubMed     Abstract available

  82. HOSHINO I, Ishige F, Iwatate Y, Gunji H, et al
    Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0248016.
    PubMed     Abstract available

  83. SHIMADA Y, Matsubayashi J, Saito A, Ohira T, et al
    Small RNA sequencing to differentiate lung squamous cell carcinomas from metastatic lung tumors from head and neck cancers.
    PLoS One. 2021;16:e0248206.
    PubMed     Abstract available

  84. HAN S, Jin S, Yoo SH, Lee HS, et al
    A practical individualized radiation precaution based on the dose rate at release time after inpatient 131I ablation therapy.
    PLoS One. 2021;16:e0251627.
    PubMed     Abstract available

  85. SASAKI F, Kanmura S, Oda K, Maeda H, et al
    Acetaldehyde breath test as a cancer risk marker in patients with esophageal and hypopharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0251457.
    PubMed     Abstract available

  86. WANG B, Tang D, Liu Z, Wang Q, et al
    LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.
    PLoS One. 2021;16:e0251797.
    PubMed     Abstract available

  87. PAO TH, Chen YY, Chang WL, Chang JS, et al
    Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0251811.
    PubMed     Abstract available

  88. HU Y, Ai LS, Zhou LQ
    Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251202.
    PubMed     Abstract available

  89. ZHOU Y, Tian M, Gungor C, Wang D, et al
    Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis.
    PLoS One. 2021;16:e0251555.
    PubMed     Abstract available

  90. RANKOVIC N, Todorovic J, Simic R
    Clinical and ultrasound characteristics of pediatric lateral neck masses.
    PLoS One. 2021;16:e0251563.
    PubMed     Abstract available

  91. CHANG SW, Tsai YH, Hsu CM, Huang EI, et al
    Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    PLoS One. 2021;16:e0251455.
    PubMed     Abstract available

  92. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    PubMed     Abstract available

  93. CHEONG TY, Hong SD, Jung KW, So YK, et al
    The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size.
    PLoS One. 2021;16:e0251446.
    PubMed     Abstract available

  94. JIANG Y, Zhang C, Shen W, Li Y, et al
    Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
    PLoS One. 2021;16:e0255479.
    PubMed     Abstract available

  95. MATSUNAGA H, Orita M, Taira Y, Takamura N, et al
    Risk perception of the pre-distribution of stable iodine to guardians of children living around the Genkai Nuclear Power Plant, Saga Prefecture, Japan.
    PLoS One. 2021;16:e0250570.
    PubMed     Abstract available

  96. YOON JK, Jang JY, An YS, Lee SJ, et al
    Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    PLoS One. 2021;16:e0254844.
    PubMed     Abstract available

  97. GEENS M, Stappers S, Konings H, De Winter BY, et al
    Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
    PLoS One. 2021;16:e0252646.
    PubMed     Abstract available

  98. YU G, Yu W, Xu X, Ye B, et al
    Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
    PLoS One. 2021;16:e0252829.
    PubMed     Abstract available

  99. LIN S, Liu T, Chen J, Li G, et al
    Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis.
    PLoS One. 2021;16:e0252751.
    PubMed     Abstract available

  100. FANG L, Shi L, Wang W, Wu X, et al
    Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer.
    PLoS One. 2021;16:e0253545.
    PubMed     Abstract available

  101. MIARI R, Azzam N, Bar-Shalom R, Fares F, et al
    5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.
    PLoS One. 2021;16:e0253756.
    PubMed     Abstract available

  102. LEE H, Paeng JC, Choi H, Cho SW, et al
    Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration.
    PLoS One. 2021;16:e0256727.
    PubMed     Abstract available

  103. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
    Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
    PLoS One. 2021;16:e0253893.
    PubMed     Abstract available

  104. PAN XB, Huang ST, Qu S, Chen KH, et al
    Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma.
    PLoS One. 2021;16:e0253424.
    PubMed     Abstract available

  105. DE C FERREIRA C, Dufloth R, de Carvalho AC, Reis RM, et al
    Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma.
    PLoS One. 2021;16:e0253418.
    PubMed     Abstract available

  106. KIM HB, Kim GJ, Han KD, Joo YH, et al
    Changes in metabolic syndrome status and risk of laryngeal cancer: A nationwide cohort study.
    PLoS One. 2021;16:e0252872.
    PubMed     Abstract available

  107. SHINOHARA Y, Washio J, Kobayashi Y, Abiko Y, et al
    Hypoxically cultured cells of oral squamous cell carcinoma increased their glucose metabolic activity under normoxic conditions.
    PLoS One. 2021;16:e0254966.
    PubMed     Abstract available

  108. ALLEN DZ, Aljabban J, Silverman D, McDermott S, et al
    Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis.
    PLoS One. 2021;16:e0258187.
    PubMed     Abstract available

  109. BOHLAND M, Tharun L, Scherr T, Mikut R, et al
    Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis.
    PLoS One. 2021;16:e0257635.
    PubMed     Abstract available

  110. MEYER TJ, Gerhard-Hartmann E, Lodes N, Scherzad A, et al
    Pilot study on the value of Raman spectroscopy in the entity assignment of salivary gland tumors.
    PLoS One. 2021;16:e0257470.
    PubMed     Abstract available

  111. CUI Y, Kim HS, Cho ES, Han D, et al
    Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
    PLoS One. 2021;16:e0256979.
    PubMed     Abstract available

  112. MUNSAMY Y, Seedat RY, Sekee TR, Bester PA, et al
    Complete genome sequence of a HPV31 isolate from laryngeal squamous cell carcinoma and biological consequences for p97 promoter activity.
    PLoS One. 2021;16:e0252524.
    PubMed     Abstract available

  113. SCHUON R, Schwarzensteiner J, Paasche G, Lenarz T, et al
    Functional aspects of the Eustachian tube by means of 3D-modeling.
    PLoS One. 2021;16:e0244909.
    PubMed     Abstract available

  114. DICKEY BL, Sirak B, Martin-Gomez L, Reich RR, et al
    Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    PLoS One. 2021;16:e0254161.
    PubMed     Abstract available

  115. TAKENAKA Y, Takemoto N, Oya R, Inohara H, et al
    Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis.
    PLoS One. 2021;16:e0259288.
    PubMed     Abstract available

  116. MEIER V, Czichon F, Walsh L, Rohrer Bley C, et al
    Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
    PLoS One. 2021;16:e0259112.
    PubMed     Abstract available

  117. SHI Y, Zhang Y, Niu Y, Chen Y, et al
    Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis.
    PLoS One. 2021;16:e0257425.
    PubMed     Abstract available

  118. DENNING SK, Valleau MA, Pelowski WJ, Chaisson CM, et al
    An automatic water-occluding device to enable laryngectomee participation in water activities.
    PLoS One. 2021;16:e0257463.
    PubMed     Abstract available

  119. PLOYPETCH S, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Salivary proteomics in monitoring the therapeutic response of canine oral melanoma.
    PLoS One. 2021;16:e0256167.
    PubMed     Abstract available

  120. KIM TY, Lee JY, Lee YJ, Park DW, et al
    CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
    PLoS One. 2021;16:e0255835.
    PubMed     Abstract available

  121. STAIRS DB, Landmesser ME, Aliaga C, Chen KM, et al
    Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide.
    PLoS One. 2021;16:e0259998.
    PubMed     Abstract available

  122. ARORA C, Kaur D, Naorem LD, Raghava GPS, et al
    Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway.
    PLoS One. 2021;16:e0259534.
    PubMed     Abstract available

  123. TAMIN S, Adham M, Noer A, Supriana N, et al
    Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation.
    PLoS One. 2021;16:e0261110.
    PubMed     Abstract available

  124. WU CN, Wu SC, Chen WC, Yang YH, et al
    Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study.
    PLoS One. 2021;16:e0260772.
    PubMed     Abstract available

  125. YAO C, Li Y, Luo L, Xiong Q, et al
    Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
    PLoS One. 2021;16:e0260353.
    PubMed     Abstract available

  126. YOSHIDA K, Kodama Y, Tanaka Y, Pak K, et al
    Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients.
    PLoS One. 2021;16:e0260026.
    PubMed     Abstract available

  127. LIM YJ, Kong M
    Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma.
    PLoS One. 2021;16:e0259384.
    PubMed     Abstract available

  128. LIU KYP, Zhu SY, Harrison A, Chen ZY, et al
    Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma.
    PLoS One. 2021;16:e0259529.
    PubMed     Abstract available

  129. GOVINDARAJ PK, Kallarakkal TG, Mohd Zain R, Tilakaratne WM, et al
    Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).
    PLoS One. 2021;16:e0261575.
    PubMed     Abstract available

  130. KANETAKE H, Kato-Kogoe N, Terada T, Kurisu Y, et al
    Short communication: Distribution of phospholipids in parotid cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry.
    PLoS One. 2021;16:e0261491.
    PubMed     Abstract available

  131. YOON J, Choi Y, Jang J, Shin NY, et al
    Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
    PLoS One. 2021;16:e0261233.
    PubMed     Abstract available

  132. FAHEY PP, Page A, Astell-Burt T, Stone G, et al
    Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time.
    PLoS One. 2021;16:e0261416.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.